The glucose regulation effect of different molecular weight chitosan on mice fed high-fat diet

Authors

ZHANG Sicong, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China; State Key Laboratory of Food Science and Technology, Wuxi, Jiangsu 214122, China
XIA Wenshui, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China; State Key Laboratory of Food Science and Technology, Wuxi, Jiangsu 214122, China
WANG Bin, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China; State Key Laboratory of Food Science and Technology, Wuxi, Jiangsu 214122, China; Jiangsu HiLong International Trading Co., Ltd, Huai’an, Jiangsu 223005, China
YANG Shuo, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China; State Key Laboratory of Food Science and Technology, Wuxi, Jiangsu 214122, China

Abstract

In order to compare the glucose regulation effect of different molecular weight chitosan on mice fed high-fat diet, 48 male C57BL/6J mice were randomly assigned to four groups, The control group (Control), which consumed a normal diet, The HF group (HF), which was fed with a high-fat diet, The HF+LWMC and HF+HWMC groups, which were fed with a high-fat diet supplement with 5% low weight molecular chitosan and 5% high weight molecular chitosan, respectively. The diet intake and weight data were collected weekly. The biochemical indicators of serum and liver and the gene expression of PEPCK and G6Pase were determined at the end of the 16 week. The results indicated that supplementation of chitosan could reduce body weights, decrease the levels of serum lipid, and alleviate the liver lipid peroxidation of HF mice. Also, high weight molecular chitosan showed better hypolipidemic effect than low weight molecular chitosan.

Publication Date

4-28-2017

First Page

122

Last Page

126

DOI

10.13652/j.issn.1003-5788.2017.04.024

Recommended Citation

Sicong, ZHANG; Wenshui, XIA; Bin, WANG; and Shuo, YANG (2017) "The glucose regulation effect of different molecular weight chitosan on mice fed high-fat diet," Food and Machinery: Vol. 33: Iss. 4, Article 24.
DOI: 10.13652/j.issn.1003-5788.2017.04.024
Available at: https://www.ifoodmm.cn/journal/vol33/iss4/24

References

［1］ 张继媛, 刘金福, 肖萍, 等 三种植物提取物对Ⅱ型糖尿病小鼠糖脂代谢改善作用研究［J］. 食品与机械, 2016, 32(12): 142-147.
［2］ HOSSAIN P, KAWAR B, NAHAS M E. Obesity and diabetes in the developing world - A growing challenge［J］. New England Journal of Medicine, 2007, 356(3): 213-215.
［3］ ANDREASEN C H, ANDERSEN G. Gene-environment interactions and obesity - Further aspects of genomewide association studies［J］. Nutrition, 2009, 25(10): 998-1 003.
［4］ CHAKAROUN R. Type 2 diabetes in obesity［J］. Diabetologe, 2014, 10(7): 581-582.
［5］ DEA T L. Pediatric Obesity & Type 2 Diabetes［J］. Mcn-the American Journal of Maternal-Child Nursing, 2011, 36(1): 42-48.
［6］ SHAW J E, SICREE R A, ZIMMET P Z. Global estimates of the prevalence of diabetes for 2010 and 2030［J］. Diabetes Research and Clinical Practice, 2010, 87(1): 4-14.
［7］ AHMED T A, ALJAEID B M. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery［J］. Drug Design Development and Therapy, 2016, 10: 483-507.
［8］ CHOPRA S, MAHDI S, KAUR J, et al. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery［J］. Journal of Pharmacy and Pharmacology, 2006, 58(8): 1 021-1 032.
［9］ ZHANG Ling-ling, YAO Li, LI Ping. Application of chitosan and its derivatives in intelligent drug delivery system［J］. Chinese Journal of Biochemical Pharmaceutics, 2012, 33(1): 81-84.
［10］ WANG Zhi-hua, YAN Yong-bin, JIANG Yang-yang, et al. Effect of orally administered hydroxypropyl chitosan on the levels of iron, copper, zinc and calcium in mice［J］. International Journal of Biological Macromolecules, 2014, 64: 25-29.
［11］ PHILIBERT T, LEE B H, FABIEN N. Current Status and New Perspectives on Chitin and Chitosan as Functional Biopolymers［J］. Applied Biochemistry and Biotechnology, 2016: 1-24.
［12］ SUGANO M, FUJIKAWA T, HIRATSUJI Y, et al. A novel use of chitosan as a hypocholesterolemic agent in rats［J］. The American journal of clinical nutrition, 1980, 33(4): 787-793.
［13］ SIMUNEK J, BARTONOVA H. Effect of dietary chitin and chitosan on cholesterolemia of rats［J］. Acta Veterinaria Brno, 2005, 74(4): 491-499.
［14］ HSIEH Y L, YAO H T, CHENG R S, et al. Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats［J］. Journal of Medicinal Food, 2012, 15(5): 453-460.
［15］ XIAO Ding-fu, TANG Zhi-ru, YIN Yu-long, et al. Effects of dietary administering chitosan on growth performance, jejunal morphology, jejunal mucosal sIgA, occluding, claudin-1 and TLR4 expression in weaned piglets challenged by enterotoxigenic Escherichia coli［J］. International Immunopharmacology, 2013, 17(3): 670-676.
［16］ GADES M D, STERN J S. Chitosan supplementation and fecal fat excretion in men［J］. Obesity Research, 2003, 11(5): 683-688.
［17］ KHOR E, LIM L Y. Implantable applications of chitin and chitosan［J］. Biomaterials, 2003, 24(13): 2 339-2 349.
［18］ QIN Cai-qin, LI Hui-rong, XIAO Qi, et al. Water-solubility of chitosan and its antimicrobial activity［J］. Carbohydrate Polymers, 2006, 63(3): 367-374.
［19］ CHOI Y S, CHO S H, KIM H J, et al. Effects of soluble dietary fibers on lipid metabolism and activities of intestinal disaccharidases in rats［J］. Journal of Nutritional Science and Vitaminology, 1998, 44(5): 591-600.
［20］ FERNANDES J C, TAVARIA F K, SOARES J C, et al. Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems［J］. Food Microbiology, 2008, 25(7): 922-928.
［21］ 陈瑞飞, 肖晗, 张幼怡. 二甲双胍通过激活AMPK和抑制HNF4α而抑制血管紧张素II引起的TGF-β1产生［J］. 中国病理生理杂志, 2015(10): 1 791.
［22］ CHANAS S A, JIANG Q, MCMAHON M, et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice［J］. Biochemical Journal, 2002, 365: 405-416.
［23］ CHARTOUMPEKIS D V, SYKIOTIS G P. Bardoxolone Methyl in Type 2 Diabetes and Advanced Chronic Kidney Disease［J］. New England Journal of Medicine, 2014, 370(18): 1 767.
［24］ BEDDOW S A, SAMUEL V T. Fasting hyperglycemia in the Goto-Kakizaki rat is dependent on corticosterone: a confounding variable in rodent models of type 2 diabetes［J］. Disease Models & Mechanisms, 2012, 5(5): 681-685.
［25］ KIM H-J, JEE H J, YUN J. DNA damage induces down-regulation of PEPCK and G6P gene expression through degradation of PGC-1 alpha［J］. Acta Biochimica Et Biophysica Sinica, 2011, 43(8): 589-594.
［26］ YOSHIUCHI I, SHINGU R, NAKAJIMA H, et al. Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients［J］. Journal of Clinical Endocrinology & Metabolism, 1998, 83(3): 1 016-1 019.
［27］ GOMEZ-VALADES A G, MENDEZ-LUCAS A, VIDAL-ALABRO A, et al. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice［J］. Diabetes, 2008, 57(8): 2 199-2 210.
［28］ LIU S-H, CHANG Y-H, CHIANG M-T. Chitosan Reduces Gluconeogenesis and Increases Glucose Uptake in Skeletal Muscle in Streptozotocin-Induced Diabetic Rats［J］. Journal of Agricultural and Food Chemistry, 2010, 58(9): 5 795-5 800.